Regenovue Non-Lidocaine: A Professional Overview for Aesthetic Practices

Regenovue Non-Lidocaine is a hyaluronic acid (HA) based dermal filler manufactured by NeoGenesis Co., Ltd., a South Korean company. It is formulated without lidocaine, offering professionals an option for patients who may have sensitivities or for specific procedural preferences. This product is intended for professional use within licensed aesthetic practices.

As a hyaluronic acid dermal filler, Regenovue Non-Lidocaine integrates into the existing range of aesthetic injectables available for clinics. It aligns with products intended for volume restoration and contouring, serving as a staple in many professional repertoires.

The primary active component in Regenovue Non-Lidocaine is cross-linked hyaluronic acid. While specific concentrations and cross-linking technologies can vary across products within the Regenovue line, this particular formulation is presented for general aesthetic indications. Each unit is typically supplied in a sterile, pre-filled syringe, accompanied by appropriate needles for professional administration.

Its non-lidocaine formulation means practitioners control any local anesthetic application separately, based on individual patient needs and procedural protocols. This can be a strategic choice for practitioners who prefer precise control over anesthetic agents.

Regenovue Non-Lidocaine is designed for various aesthetic applications, depending on the specific product variant within the Regenovue range. Generally, hyaluronic acid fillers are employed for restoring facial volume, smoothing lines, and enhancing contours. The specific rheological properties of a filler dictate its suitability for particular facial areas and injection depths.

Professionals select fillers based on viscosity, elasticity, and particle size to match the intended anatomical area and desired aesthetic outcome. For instance, fillers might be used for fine lines, medium wrinkles, or deeper volume restoration. The absence of lidocaine allows for observation of patient comfort during the procedure without the masking effect of the anesthetic.

The duration of effect for any hyaluronic acid dermal filler, including Regenovue Non-Lidocaine, is influenced by several factors. These include the patient's individual metabolism, the specific product's cross-linking technology, the injection site, and the volume administered. Information regarding product longevity is typically provided by the manufacturer based on their research.

Practitioners often communicate typical informational duration ranges to patients, understanding that individual results may vary. This transparency helps manage patient expectations and informs follow-up treatment planning. Other non-lidocaine options exist, such as Elasty Plus Non-Lido 2CC, which offer similar flexibility in anesthetic management.

Sourcing Regenovue Non-Lidocaine for your clinic involves consideration of wholesale pricing tiers and supplier reliability. At an illustrative wholesale price of $75.8 per unit, volume discounts are typically available:

• 11+ units: 4% discount
• 21+ units: 5% discount
• 31+ units: 6% discount
• 51+ units: 8% discount

These tiers allow clinics to optimize their procurement costs based on anticipated usage. Exploring various Hyaluronic acid dermal filler catalog options can also reveal comparable products and pricing structures. For a reference, professionals can review the D.Fill Soft Wholesale Price Guide for Aesthetic Professional.